Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Bioeng. Biotechnol.

Sec. Organoids and Organ-On-A-Chip

Volume 13 - 2025 | doi: 10.3389/fbioe.2025.1684315

This article is part of the Research TopicAdvancing Disease Modeling and Therapy with Organoids and Organ-on-a-ChipView all articles

Upscaling: Efficient generation of human lung organoids from induced pluripotent stem cells using a stirring bioreactor

Provisionally accepted
Diana  KleinDiana Klein*Bettina  BudeusBettina BudeusChiara  KroepelChiara KroepelZehra  Fatma SevindikZehra Fatma SevindikLuca  ButtlerLuca Buttler
  • University of Duisburg-Essen, Duisburg, Germany

The final, formatted version of the article will be published soon.

Human induced pluripotent stem cells (iPSCs) can be successfully differentiated into complex (three-dimensional) lung spheroids or organoids and have thus proven to be promising in vitro tools that provide a robust system for simulating lung disease and modeling drug response. We previously described a very simple and practical protocol for producing iPSC-derived lung organoids (iPSC-LuOrgs) in ultra-low attachment plates without relying on a gel-like extracellular matrix. Here, we attempted to produce these organoids in a stirred-tank bioreactor equipped with a unique membrane stirrer and compared this type of up-scaled and more automated cultivation with the manual variant. For this purpose, detailed morphological and molecular analyses, including single-cell RNA sequencing, of the differently generated LuOrgs were performed. Just like in the manual variant, using the bioreactor morphologically comparable lung organoids could be obtained that showed a very similar cellular composition. This generation can also be considered as animal component-free production. These freely floating LuOrgs are now available in large numbers for the investigation of, for example, cancer therapy approaches as a new and patient-oriented in vitro platform.

Keywords: Lung, Organoids, upscaling, 3D culture, bioreactor, Bioengineering, IPSC

Received: 12 Aug 2025; Accepted: 08 Oct 2025.

Copyright: © 2025 Klein, Budeus, Kroepel, Sevindik and Buttler. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Diana Klein, diana.klein@uk-essen.de

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.